What is Altratech?
Established in 2013 and headquartered in Clare, Ireland, Altratech designs advanced biosensor and semiconductor chip technology tailored for DNA testing. This technology is crucial for ensuring food traceability within the agriculture sector, providing businesses with robust solutions for verifying the origin and safety of their products. The company's focus on precision diagnostics positions it at the intersection of biotechnology and agricultural technology, addressing growing demands for transparency and safety in the food supply chain.
How much funding has Altratech raised?
Altratech has raised a total of $29.7M across 8 funding rounds:
Angel/Seed
$1.2M
Private Equity
$1.5M
Grant
$3.4M
Unspecified
$2.5M
Multiple Rounds
$9.6M
Other Financing Round
$11.5M
Angel/Seed (2014): $1.2M with participation from Enterprise Ireland and Kernel Capital
Private Equity (2016): $1.5M led by Kernel Capital
Grant (2017): $3.4M, investors not publicly disclosed
Unspecified (2017): $2.5M featuring Kernel Capital Growth Fund
Other Financing Round (2021): $4.1M, investors not publicly disclosed
Unspecified (2021): $3.9M with participation from The Bank of Ireland Kernel Capital Growth Fund and Infinity Capital
Debt (2021): $1.6M led by Claret Capital
Other Financing Round (2024): $11.5M supported by European Innovation Council and SMEs Executive Agency (EISMEA
Key Investors in Altratech
Kernel Capital
Kernel Capital is a venture capital and private equity firm that specializes in investing in growth stage and early stage companies. With a strong focus on providing not just capital but also strategic guidance, they support their portfolio companies in scaling and achieving successful exits.
Enterprise Ireland
Enterprise Ireland is a government agency responsible for the development and growth of Irish businesses in the manufacturing and internationally traded services industries.
Claret Capital
Claret Capital is a company that operates in the Lending & Brokerage industry. It employs 1to4 people and has under500K of revenue.
What's next for Altratech?
The recent major strategic investment signifies a pivotal moment for Altratech, indicating a strong market validation and a clear path for accelerated growth and innovation. This influx of capital is expected to fuel further research and development in their biosensor and semiconductor chip technologies, potentially expanding their application scope within agriculture and beyond. The company's trajectory suggests a move towards scaling its operations, enhancing its market penetration, and solidifying its position as a leader in food traceability solutions through advanced DNA testing.
See full Altratech company page
